AI Verdict
ABT has stronger fundamentals based on our AI analysis.
ABT vs ELV Fundamental Comparison
| Metric | ABT | ELV |
|---|---|---|
| Revenue | $44.3B | $199.1B |
| Net Income | $6.5B | $5.7B |
| Net Margin | 14.7% | 2.8% |
| ROE | 12.5% | 12.9% |
| ROA | 7.5% | 4.7% |
| Current Ratio | 1.58x | 1.54x |
| Debt/Equity | 0.25x | 0.73x |
| EPS | $3.72 | $25.21 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs ELV: Frequently Asked Questions
Is ABT or ELV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABT is rated BUY (77% confidence) while ELV is rated BUY (75% confidence). This is not investment advice.
How does ABT compare to ELV fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs Elevance Health, Inc.'s 12.9%. Net margins are 14.7% vs 2.8% respectively.
Which stock pays higher dividends, ABT or ELV?
ABT has a dividend yield of N/A or no dividend while ELV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or ELV for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while ELV has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs ELV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs ELV, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.